These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam. Jones RN, Barry AL, Thornsberry C, Fuchs PC, Packer RR. Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130 [Abstract] [Full Text] [Related]
4. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases. Raimondi A, Mattina R, Cocuzza CE. Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365 [Abstract] [Full Text] [Related]
5. The in-vitro activity and beta-lactamase stability of carumonam. Neu HC, Chin NX, Labthavikul P. J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143 [Abstract] [Full Text] [Related]
8. Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic. Angehrn P. Chemotherapy; 1985 Jul; 31(6):440-50. PubMed ID: 3935396 [Abstract] [Full Text] [Related]
9. [Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics]. Vanhoof R, Nyssen HJ, Nulens E, Roebben E, Hubrechts JM. Pathol Biol (Paris); 1990 Jun; 38(6):634-7. PubMed ID: 2165238 [Abstract] [Full Text] [Related]
10. Comparative in vitro antimicrobial activity of carumonam (Ro 17-2301) and its influence on the activity of other antibiotics. Hoepelman IM, Steyger G, Rozenberg-Arska M, Verhoef J. Chemotherapy; 1987 Jun; 33(2):103-9. PubMed ID: 3568798 [Abstract] [Full Text] [Related]
11. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam. Smith BR, LeFrock JL, McCloskey RV, Donato JB, Weber SJ, Joseph WS. Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280 [Abstract] [Full Text] [Related]
12. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates. Barclay CA, Iribarren MA, Goldberg M, Traballi CA, Casellas JM. Chemotherapy; 1987 Feb; 33(3):165-71. PubMed ID: 3595259 [Abstract] [Full Text] [Related]
13. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams]. Labia R, Morand A, Pitton JS, Philippin JL, Fournier P. Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817 [Abstract] [Full Text] [Related]
19. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM. J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [Abstract] [Full Text] [Related]
20. In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila. Hohl P, von Graevenitz A, Zollinger-Iten J. Antimicrob Agents Chemother; 1988 Oct; 32(10):1593-4. PubMed ID: 3190188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]